Table 1.

Donor features corresponding to the source of CAFs used for experimentation in this study.

Number	Age	Sex	Tumor type	T-size (mm)	T-stage and N-stage
Donor 1	60	F	MD-SCC	35	pT2aN0
Donor 2	67	F	MD-SCC	30	pT1bN0
Donor 3	62	F	BAA	12	pT1aN0
Donor 4	57	F	MD-AC	30	pT2aN1
Donor 5	64	F	LD-AC	30	pT1bN0
Donor 6	58	M	MD-AC	60	pT2bN0
Donor 7	60	F	BAA	6	pT1aN0

BAA, bronchio-alveolar adenocarcinoma; AC, adenocarcinoma; SCC, squamous cell carcinoma; LCC, large cell carcinoma; M, male; F, female; HD, highly differentiated, MD, middle differentiated; LD, low differentiated.